Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies

By A. Andriulli, S. Loperfido, G. Napolitano, G. Niro, M. Valvano, F. Spirito, A. Pilotto, R. Forlano. American Journal of Gastroenterology, 2007

1,240 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EASL Clinical Practice Guidelines: management of cholestatic liver diseases. (2009, background): “ERCP and endoscopic therapy Diagnostic ERCP has been the procedure of choice for suspected PSC in the past, but is associated with significant risks including pancreatitis and cholangitis [125,126].”
Adverse events associated with ERCP. (2017, background): “Post-ERCP pancreatitis (PEP) is the most common serious adverse event attributed to the procedure, resulting in annual estimated costs exceeding 150 million dollars in the United States.2,3 Controversy exists on how PEP should be defined.”
ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2019, background): “4% of ERCPs in the abovementioned meta-analysis of 2007 [12]; 20% of these were considered severe events and the mortality rate was 0.”